AstraZeneca: Corona vaccine discontinued: suspected adverse reaction
September 9, 2020 7:02 JST
According to STAT:
One UK study participant suspected of serious adverse reactions.
AstraZeneca’s ADR was temporarily down 8.3% in the US stock market overtime trading on September 8.
“The Phase 3 trial of the new coronavirus vaccine being co-developed with Oxford University in the UK has been put on hold,” the report was disliked.
Press-Bloomberg
https://www.bloomberg.co.jp/news/articles/2020-09-08/QGD081DWRGG001
AstraZeneca Covid-19 vaccine study is put on hold
A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford
at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.
A spokesperson for AstraZeneca,
a frontrunner in the race for a Covid-19 vaccine, said in a statement thatthe company’s “standard review process triggered a pause to vaccination to allow review of safety data.”
It was not immediately clear who placed the hold on the trial, though it is possible it was placed voluntarily by AstraZeneca and not ordered by any regulatory agency.
The nature of the adverse reaction and when it happened
were also not immediately known, though the participant is expected to recover, according to an individual familiar with the matter.